Investigation of Clinical Feature and Brain Function in Narcoleptic Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03376568 |
Recruitment Status : Unknown
Verified December 2017 by Tang-Du Hospital.
Recruitment status was: Recruiting
First Posted : December 18, 2017
Last Update Posted : December 18, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Narcolepsy REM Sleep Behavior Disorder |
Polysomnographic (PSG) work-up one night to record nocturnal sleep condition in narcolepsy with /without RBD and control subjects including sleep macrostructure, occurrence of sleep onset rapid eye movement period(SOREMP), sleep stages distribution, and sleep arousle and leg movement and apnea hyponea index would be calculated.
Functional magnetic resonance imaging (fMRI) has been used in human to nonivasiverlyn investigate the neural mechanisms. This technique also apply to measures the variations in brain perfusion, structure and morphology in narcolepsy patients by assessing the blood oxygen level-dependent (BOLD) signal diffusion tensor imaging (DTI and voxel-based morphometry(VBM)
This study compare the feature of PSG and fMRI between narcolepsy with RBD, narcolepsy without RBD, control subject to evaluates the PSG and cerebral metabolism and functions in narcolepsy with/without RBD.
Study Type : | Observational |
Estimated Enrollment : | 100 participants |
Observational Model: | Case-Control |
Time Perspective: | Cross-Sectional |
Official Title: | Feature of Polysomnography and Cerebral Metabolism and Function in Narcolepsy With/Without RBD and Control Subject |
Actual Study Start Date : | January 28, 2016 |
Estimated Primary Completion Date : | December 30, 2017 |
Estimated Study Completion Date : | December 30, 2019 |

Group/Cohort |
---|
Narcolepsy with RBD & Control
Narcolepsy with REM sleep disorder lable(20) and Control subjects lable(20)
|
Narcolepsy with /without RBD
Narcolepsy with REM sleep disorder lable(20) and Narcolepsy without REM sleep disorderlable (20)
|
- video-polysomnographic(PSG) [ Time Frame: up to 100 weeks ]video-PSG monitor sleep from 9:00pm to 6:00am
- multiple sleep latency test (MSLT) [ Time Frame: up to 100 weeks ]MSLT in the next day of PSG record daytime sleepiness
- functional magnetic resonance imaging (fMRI) [ Time Frame: up to 100 weeks ]All narcolepsy with or withoutRBD accepts fMRI

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 10 Years to 65 Years (Child, Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Narcolepsy meet to the international classification of sleep disorder,3rd edition (ICSD-3) , and RBD meet to the minimal diagnostic criteria according to the international Classification of Sleep, control subjects .
Exclusion Criteria:
History of heart disease History of central nervous system organic psychosis AHI>15次/h History of alcohol dependence and drug abuse

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03376568
Contact: Guoyan Chen, MD | 86-02984717792 | chenguoyan29@126.com | |
Contact: Wen Wang, PhD | 86-02984778689 | wangwen@fmmu.edu.cn |
China, Shan | |
Tangdu Hospital | Recruiting |
Xi'an, Shan, China, 710000 | |
Contact: Guoyan Chen, MD 86-02984717792 chenguoyan29@126.com | |
Contact: Wen Wang, PhD 86-029778689 wangwen@fmmu.edu.cn |
Responsible Party: | Tang-Du Hospital |
ClinicalTrials.gov Identifier: | NCT03376568 |
Other Study ID Numbers: |
TDLL-201601-08 |
First Posted: | December 18, 2017 Key Record Dates |
Last Update Posted: | December 18, 2017 |
Last Verified: | December 2017 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
polysomnographic multiple sleep latency test fMRI |
Narcolepsy REM Sleep Behavior Disorder Mental Disorders Disorders of Excessive Somnolence Sleep Disorders, Intrinsic |
Dyssomnias Sleep Wake Disorders Nervous System Diseases REM Sleep Parasomnias Parasomnias |